Serum MUC5AC levels have been shown to be increased in patients with PDAC compared with both benign and chronic pancreatitis cohorts, with MUC5AC performing on par with CA19-9, though again, the combination of the two produced the best results (73, 74). Here, MUC5AC is linked to chronic pancreatitis.